Table 1

Treatment strategy and devices

Treatment strategyn (%)
IAT only5 (9.8%)
Mechanical thrombectomy only23 (45.1%)
IVT+mechanical thrombectomy7 (13.7%)
IAT+mechanical thrombectomy15 (29.4%)
IVT+IAT+mechanical thrombectomy1 (2.0%)
Overall51
Devices
 Mechanical thrombectomy30 (58.9%)
  Trevo15 (29.4%)
  Penumbra4 (7.8%)
  Solitaire3 (5.9%)
  Trevo+Solitaire3 (5.9%)
  Trevo+Penumbra2 (3.9%)
  Other3 (5.9%)
 Mechanical thrombectomy+IAT16 (31.4%)
  Penumbra+IAT9 (17.6%)
  Trevo+IAT4 (7.8%)
  Solitaire+IAT2 (3.9%)
  Other+IAT1 (2.0%)
 Stent
  ‘Koronar Integrity’5 (9.8%)
Overall51
  • IAT, IA thrombolysis with recombinant tissue plasminogen activator; IVT, IV thrombolysis with recombinant tissue plasminogen activator.